Adagio Medical Holdings (ADGM) Preferred Stock Liabilities (2023 - 2024)
Adagio Medical Holdings (ADGM) reported Preferred Stock Liabilities of $91.5 million for Q4 2024, little changed year-over-year from $91.5 million in Q1 2024, and up 5.4% quarter-over-quarter from $86.8 million in Q2 2024.
Adagio Medical Holdings (ADGM) Preferred Stock Liabilities (2023 - 2024) Analysis & Trends
Adagio Medical Holdings (ADGM) has 2 years of Preferred Stock Liabilities data on file, last reported at $91.5 million in Q4 2024.
- Preferred Stock Liabilities for Q4 2024 came in at $91.5 million, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2024 was $91.5 million (changed 0.0% YoY), and the FY2024 annual result was $91.5 million, changed 0.0% from the prior year.
- Preferred Stock Liabilities improved to $91.5 million in Q4 2024 per ADGM's latest filing, from $86.8 million in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $91.5 million in Q3 2023 and troughed at $86.8 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Adagio Medical Holdings | 15.88 Mn | 2.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 91.47 Mn |
| Jun 30, 2024 | 86.78 Mn |
| Mar 31, 2024 | 91.47 Mn |
| Dec 31, 2023 | 91.47 Mn |
| Sep 30, 2023 | 91.47 Mn |